Recent publications published by researchers at the MRC WIMM.
Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease.
Journal article
Serra EG. et al, (2022), Nat Commun, 13
Correction to: An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment.
Journal article
Motohara T. et al, (2022), Oncogene
Investigation of the potential mechanisms underlying nuclear F-actin organization in ovarian cancer cells by high-throughput screening in combination with deep learning
Journal article
AHMED A. et al, (2022), Frontiers in Cell and Developmental Biology
CIDER: an interpretable meta-clustering framework for single-cell RNA-seq data integration and evaluation
Journal article
Hu Z. et al, (2021), Genome Biology, 22
Neoadjuvant chemotherapy induces genomic and transcriptomic changes in ovarian cancer.
Journal article
Javellana M. et al, (2021), Cancer Res
Studying Müllerian duct anomalies - from cataloguing phenotypes to discovering causation.
Journal article
Santana González L. et al, (2021), Dis Model Mech, 14
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor initiating cells.
Journal article
Artibani M. et al, (2021), JCI Insight
General anaesthetic and airway management practice for obstetric surgery in England: a prospective, multicentre observational study.
Journal article
Odor PM. et al, (2021), Anaesthesia, 76, 460 - 471
Mechanistic Drivers of Müllerian Duct Development and Differentiation Into the Oviduct
Journal article
Santana Gonzalez L. et al, (2021), Frontiers in Cell and Developmental Biology
Mechanistic Drivers of Müllerian Duct Development and Differentiation Into the Oviduct
Journal article
Santana Gonzalez L. et al, (2021), Frontiers in Cellular and Infection Microbiology
The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers.
Journal article
Hu Z. et al, (2021), Clin Cancer Res, 27, 1570 - 1579
The Zinc Finger Protein Zbtb18 Represses Expression of Class I Phosphatidylinositol 3-Kinase Subunits and Inhibits Plasma Cell Differentiation.
Journal article
Xie B. et al, (2021), J Immunol
Subtraction-free and bisulfite-free specific sequencing of 5-methylcytosine and its oxidized derivatives at base resolution.
Journal article
Liu Y. et al, (2021), Nat Commun, 12
A novel salt inducible kinase 2 inhibitor, ARN-3261, sensitizes ovarian cancer cell lines and xenografts to carboplatin
Journal article
Fan D. et al, (2021), Cancers
Promises and challenges of adoptive T-cell therapies for solid tumours
Journal article
AHMED A. et al, (2021), British Journal of Cancer
Mechanistic Drivers of Müllerian Duct Development and Differentiation Into the Oviduct.
Journal article
Santana Gonzalez L. et al, (2021), Front Cell Dev Biol, 9
A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals.
Journal article
Demetriou P. et al, (2020), Nat Immunol, 21, 1232 - 1243
Novel SIK2 inhibitors sensitize ovarian and breast cancer to PARP inhibitors
Conference paper
Lu Z. et al, (2020), CANCER RESEARCH, 80
Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells.
Conference paper
Prota G. et al, (2020), Cancer Immunol Res, 8, 685 - 697
A highly accurate platform for clone-specific mutation discovery enables the study of active mutational processes.
Journal article
KaramiNejadRanjbar M. et al, (2020), Elife, 9